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Summary
Introduction: Within the past two decades, we made significant progress in radiation therapy for prostate cancer. At 
UH Rijeka IMRT became the technique of choice for radiation therapy following radical prostatectomy since 2016. Previ-
ously, an advanced 3-DCRT technique using the field-in-field (FiF) method was used for dose distribution optimization 
around target volumes and organs-at-risk. This research has been performed to investigate the influence of planning tech-
nique choice (FiF or IMRT) on coverage of target volumes with prescribed dose and organs-at-risk sparing.
Materials and methods: Comparison of dose distributions calculated using FiF and IMRT techniques was performed 
retrospectively for ten patients who underwent postoperative radiotherapy. The prescribed dose for all patients was deliv-
ered using IMRT, and for this research, we also calculated dose distributions using the FiF technique. For FiF and IMRT 
techniques, we used linear accelerator photon beams. To determine the influence of planning technique on dose distribution 
parameters related to target volumes (GTV, CTV, PTV1, ptV2) were analyzed. For organs-at-risk sparing evaluation (rectum, 
bladder, femoral heads), we used dose-volume constraints.
Results and discussion: The analysis of parameters related to target volumes has shown that most of them had no statis-
tically significant difference (V100%(GTV), V100%(CTV), V95%(PTV2), V95%(PTV1)). For both planning techniques, interna-
tionally set dose constraints were achieved. Statistically, we found a significant difference for V100%(PTV2), p=0,000534, and 
V100%(PTV1), p=0,042944 in favor of IMRT. A statistically significant difference (p=0,045966) was found for the volume of 
the rectum, which receives 40Gy, and for the volume of femoral heads, which receives 30Gy (p=0,000385), where the sparing 
is better for IMRT. For dose-volume constraints related to the bladder, no statistically significant differences were found.
Conclusion: Results of this research show a statistically significant difference for V100% target volume coverage for 
ptV1 and ptV2, with better dose coverage accomplished by IMRT. Concerning organs-at-risk sparing, a statistically signi-
ficant difference in favor of IMRT was found for rectum volume, which receives 40Gy. Expectedly, IMRT was superior to the 
FiF technique. However, differences between the two planning techniques were relatively small, which points to the fact 
that the FiF technique is viable as a technique of choice.
KEYWORDS:  intensity-modulated radiation therapy, field-in-field technique, postoperative prostate cancer radiotherapy,  
radiation dosimetry.





Globally, more than 50% of oncological pa-
tients require radiotherapy treatment (1). In Croa-
tia, prostate cancer makes up 17.4% of all diag-
nosed cancer cases in the male population (2). In 
cases with high-risk and very-high-risk prostate 
cancer, radical prostatectomy is followed by radi-
ation therapy (3). Recently, radiotherapy of pros-
tate cancer in salvage radiotherapy tends to be a 
standard approach for cases of biochemical recur-
rence based on postoperative prostate-specific an-
tigen (PSA) levels (4). Studies have shown that lo-
cal recurrence of the disease happened less often 
in patients who underwent radiotherapy follow-
ing radical prostatectomy (5,6). During treatment 
planning, the main challenge is the compromise 
between higher target volume coverage and better 
organs-at-risk sparing. In the past two decades, 
large progress has been made in new radiation 
technologies used to treat prostate cancers, with 
further development of medical linear accelerator, 
calculation algorithms built-in treatment planning 
system and, consequently, radiation oncology 
treatment planning techniques (7).
Intensity-modulated radiation therapy (IMRT) 
is one of the advanced treatment planning tech-
niques used in radiation therapy treatment plan-
ning following radical prostatectomy (3). It has 
been the choice technique at University Hospital 
Rijeka since 2016 when the system for dose distri-
bution calculation and optimization based on the 
Monte Carlo algorithm had been clinically imple-
mented. Formerly, the advanced 3D conformal ra-
diotherapy field in field (FiF) technique was used 
for dose distribution optimization around target 
volumes and organs-at-risk. Generally, the con-
cept of IMRT is that the dose distributions are in-
versely determined, meaning that the desired 
dose distribution optimization goals concerning 
target volume coverage and organs-at-risk spar-
ing must be specified prior to calculation. The pre-
scribed dose is to be delivered to the respective 
volumes with strict precision. Forward FiF tech-
nique is a simplified form of IMRT with a limited 
number of segments per field, whose shape and a 
physicist optimizes weight to deliver the pre-
scribed dose to the target and obtain, at least, re-
quired organs-at-risk sparing. Organs-at-risk 
sparing requires the fulfillment of dose-volume 
constraints to avoid acute and long-term side ef-
fects. For radiation oncology treatment of prostate 
cancer, it was shown that patients who developed 
acute symptoms were more likely to develop late 
toxicities for both rectum and bladder (8). Achiev-
ing as low as possible doses to organs-at-risk 
while maintaining sufficiently high target volume 
coverage helps to reduce acute and long-term tox-
icity.
This research aimed to investigate the influ-
ence of planning technique (FiF or IMRT) on pre-




Retrospective analysis of dose distributions 
for ten patients who underwent postoperative ra-
diotherapy at the Clinic for Radiotherapy and 
 Oncology of UH Rijeka was performed for this 
 research.
Pre-treatment procedures were undertaken 
in preparation for radiation oncology treatment in 
accordance with the in-house protocol. Siemens 
Somatom Open CT simulator (Siemens Health-
ineers, Erlangen, Germany) was used to acquire 
the imaging data. Computerized tomography 
(CT) was performed for all patients, who were 
scanned in the supine position with 3mm slice 
thickness. Bottom and top scan borders were set at 
the proximal part of the femur and the third lum-
bar vertebra.
Prior to the CT simulation, patients were in-
structed to follow the full bladder and empty rec-
tum preparation protocol (9). Radiation oncolo-
gist delineated target volumes using Elekta Mo-
naco Sim (ver 5.11.02, Elekta, Stockholm, Sweden) 
workstation. The prostate bed was designated as 
gross target volume (GTV) and lymph nodes as 
the clinical target volume (CTV). Planning target 
volumes (PTVs) were created in accordance with 
international guidelines (10): PTV1, created by 
adding an 0.7cm margin around CTV and a 1.0cm 
margin around GTV, and PTV2, created by adding 
a 1.0cm margin around the prostate bed (GTV). 
Relevant organs-at-risk were also delineated. 
Bladder volume was delineated as the whole blad-
der. Rectum was delineated as the region from the 
sigmoid colon superiorly to the anal canal inferi-
orly, including rectal wall and cavity. The entire 
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volume of both organs was delineated, including 
the filling. The Left and right femoral heads were 
also delineated.
The prescribed dose to be delivered to PTV1 
was 46Gy in 23 fractions with an additional 22Gy 
in 11 fractions to PTV2. Absorbed dose for IMRT 
was calculated using Monaco ver. 5.11 (Elekta, 
Stockholm, Sweden) treatment planning system. 
The prescribed dose was delivered to the patient 
using 6MV photon beams of the Siemens Oncor 
Expression (Siemens Healthineers, Erlangen, Ger-
many) linear accelerator. An arrangement of nine 
coplanar beams at gantry angles 0°, 40°, 80°, 120°, 
160°, 200°, 240°, 280°, and 320° was used. Sequenc-
ing parameters were set so that the minimum seg-
ment area was ≥4cm2, minimum segment width 
was ≥1cm, the minimal number of monitor units 
per segment was 2, and the maximum number of 
segments per treatment fraction was 100. Delivery 
mode for the IMRT was step-and-shoot.
For the purpose of this research, dose distri-
butions using the FiF technique were calculated 
retrospectively, using XiO ver. 5.10 (Elekta, Stock-
holm, Sweden) treatment planning system. Pho-
ton beams of higher nominal potential (18MV) of 
the same linear accelerator were used for treat-
ment delivery. Beams set at 0°, 90°, 150°, 180°, 
200°, and 270° were used to achieve the dose dis-
tribution conformality. Field-in-field technique 
was used at existing angles to improve conformal-
ity, dose homogeneity, eliminate dose hot spots, 
and achieve better organs-at-risk sparing.
For both planning techniques, dose-volume 
constraints for target volume coverage were set. 
They required V95% of PTV1 and ptV2 to be cov-
ered by 98% of the prescribed dose and V100% of 
the same structures to be covered by 85% of the 
prescribed dose. In addition, no more than 2% of 
the PTV volume was to receive more than 71.4Gy. 
The dose constraint for the GTV and CTV was that 
100% of the volume was covered by 98% of the 
prescribed dose (68Gy) (10).
For both planning techniques, dose con-
straints for organs-at-risk followed the dose 
guidelines designed by the QUANTEC and RTOG 
(9,11,12). For postoperative radiation treatment of 
prostate cancer, stricter criteria were used in our 
clinic. The rectum criteria require that no more 
than 60%, 50%, and 40% of the rectum volume re-
ceives absorbed dose larger than 40Gy, 50Gy, and 
60Gy, respectively. The bladder criteria require 
that no more than 50%, 25%, and 20% of the blad-
der volume receive absorbed doses larger than 
50Gy, 60Gy, 65Gy, respectively. It was required 
for femoral heads that no more than 10% of the 
volume receives more than 50Gy.
The cumulative dose-volume histograms 
(DVHs) were used for the evaluation and compar-
ison of planning techniques. DVHs were inspect-
ed for the following parameters: target volume 
coverage with 100% of prescribed dose for GTV, 
ctV, ptV1, and ptV2, target volume coverage 
with 95% prescribed dose for PTV1 and ptV2. For 
organs-at-risk sparing, dose-volume data were re-
viewed for (V40Gy, V50Gy and V60Gy), bladder (V50Gy, 
V60Gy and V65Gy) and femoral heads (V50Gy).
Statistical analysis
TIBCO Statistica ver. 13.5. software package 
was used to perform the statistical analysis. The 
differences between the two techniques in dose 
to the respective percentage volume were calcu-
lated as:
where DIMRT and DFiF are the doses to the volumeof 
interest in IMRT and FiF, respectively, and DPR is 
the prescribed dose. The differences between tech-
niques for volumes coverage with specific doses 
were calculated as:
where %VIMRT and %VFiF are the volume coverage 
for the same absorbed dose in IMRT and FiF tech-
niques, respectively.
The p-value of <0.05 was set as the level of 
significance. Along with Student’s t-test, Kruskal-
Wallis test was used as a non-parametric test and 
one-way analysis of variance (ANOVA) as a para-
metric test.
RESULTS
Analysis of parameters related to target vol-
umes (GTV, CTV, PTV1, ptV2) has shown that 
 absorbed dose coverage using IMRT was higher 
for all analyzed parameters. However, most of 
them did not show any statistically significant 
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 difference (V100%(gtV), V100%(ctV), V95%(ptV2), 
V95%(ptV1)). The results are presented in Table 1.
Statistically, a significant difference was 
found for V100% target volume coverage for PTV1 
and ptV2, with p=0,042944 and p=0,000534, re-
spectively, with higher planning target volume 
coverage achieved using IMRT.
A comparison of dose distributions regard-
ing two planning techniques was performed for 
organs-at-risk that were found to be clinically rel-
evant for the treatment outcome. The results for 
rectum, bladder, and femoral heads are shown in 
Table 2. A statistically significant difference 
(p=0,045966) was found for rectum, for criterion 
requiring that no more than 40% of the rectum 
volume receive absorbed dose larger than 60Gy. 
For dose-volume constraints related to the blad-
der, no statistically significant difference was 
found. Observing the DVHs, a difference was no-
ticed for lower doses, and the additional analysis 
was made for the percentage of femoral heads vol-
ume receiving a dose of 30Gy (V30Gy). A statisti-
cally significant difference was found (p=0,000385) 
in favor of IMRT.
Table 1.
Mean target volume coverage with corresponding standard 
deviation (GTV, CTV, PTV1, and PTV2) for IMRT and FiF, 
accompanied by p-values.
FiF IMRT p-value
GTV V100% (%) 98,8±1,3 99,9±0,2 0,056162
CTV V100% (%) 99,4±0,9 99,4±0,8 0,055424
PTV1 V100% (%) 93,3±2,0 95,8±2,4 0,042944
V95% (%) 99,3±0,6 99,9±0,1 0,060417
PTV2 V100% (%) 91,6±3,8 97,9±1,4 0,000534
V95% (%) 99,9±0,2 99,7±0,4 0,242502
Table 2.
Mean value of the organs-at-risk dose-volume coverage  
for the following dose-volume constraints: rectum (V40Gy, V50Gy 
and V60Gy), bladder (V50Gy, V60Gy and V65Gy) and femoral heads 
(V30Gy, V50Gy), accompanied with p-values.
FiF IMRT p-value
Rectum V40Gy (%) 66,64±12,9 53,43±11,14 0,045966
V50Gy (%) 45,89±14,68 38,85±11,65 0,306166
V60Gy (%) 28,23±8,62 27,486±8,93 0,867383
Bladder V50Gy (%) 49,33±18,36 38,45±10,33 0,166288
V60Gy (%) 35,41±14,61 29,91±9,76 0,390927
V65Gy (%) 28,13±12,92 25,72±9,25 0,590504
Femoral 
heads
V30Gy (%) 75,62±29,21 25,81±8,38 0,000385
V50Gy (%) 1,13%±1,64 1,23±1,54 0,924183
Figure 2.Dose distribution showing target volume coverage and 
the organs-at-risk sparing for FiF (top) and IMRT (bottom) on a 
transversal slice of the prostate bed region for one study patient.
Figure 1. Dose distribution showing target volume coverage and 
the organs-at-risk sparing for FiF (top) and IMRT (bottom) on 




Absorbed dose distribution on the same 
transversal slice of one study patient for both 
planning techniques is shown in Figures 1 and 2. 
The lymph node region is shown in Figure 1, while 
the prostate bed region is shown in Figure 2.
Dose-volume histogram (DVH) with cumu-
lative doses to target volumes and organs-at-risk 
(rectum, bladder, and femoral heads) for one 
study patient is shown in Figures 3 and 4.
DISCUSSION
The treatment of prostate cancer has evolved 
so that a substantial proportion of patients has a 
higher life expectancy after radiotherapy. Late 
toxicities from radiotherapy can significantly im-
pact the patient’s quality of life (13). According to 
the published studies, IMRT enables higher dose 
delivery to the target volumes with better sparing 
Figure 3.Dose-volume histogram displaying coverage of target volumes (GTV, CTV, PTV1, and PTV2) 
for FiF (full line) and IMRT (dotted line).
Figure 4. Dose-volume histogram displaying absorbed dose received by the organs-at-risk (bladder, 
rectum, and femoral heads) for FiF (full line) and IMRT (dotted line).
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of normal tissues compared to 3-DCRT (7,14). Re-
sults of this research confirm this statement con-
sidering some of the inspected parameters.
Target coverage of GTV with 100% of the pre-
scribed dose using the FiF technique was only 
slightly lower than GTV coverage using IMRT, 
and no statistically significant difference between 
the techniques was found in that regard. No statis-
tically significant difference was found for 100%of 
the prescribed dose volume coverage for CTV ei-
ther, where the target coverage with the absorbed 
dose was the same for both techniques. When ana-
lyzing volume coverage with 95% of the pre-
scribed dose of PTV1 and ptV2, the differences 
between the two planning techniques were minor 
and statistically insignificant. However, a statisti-
cally significant difference was found for coverage 
with 100% of the prescribed dose for PTV1 and 
ptV2 in favor of IMRT, with differences between 
target volume coverage as high as 5.03% and 
11.27%, for PTV1 and ptV2, respectively.
Target volume coverage with prescribed dose 
is significant in treatment planning; however, it 
must be achieved in compromise with dose-vol-
ume coverage of organs-at-risk. Better organs-at-
risk sparing reduces the incidence of acute and 
late toxicities in these structures (8). Comparing 
data from Tables 1 and 2 for all analyzed parame-
ters, it was found that the use of IMRT could pro-
vide better organs-at-risk sparing than the FiF 
technique. Differences in bladder sparing were 
shown to be statistically insignificant for all in-
spected dose-volume constraints. Dose-volume 
sparing was shown to be better with IMRT when 
analyzing parameters regarding rectum sparing. 
No statistically significant difference was found 
regarding the volume of the rectum receiving 
50Gy and 60Gy (V50Gy and V60Gy), but a statistically 
significant difference was found for the volume of 
the rectum receiving40Gy (V40Gy) in favor of IMRT. 
Concerning femoral heads, no statistically signifi-
cant difference was found between FiF and IMRT 
regarding the volume receiving 50Gy (V50Gy). a 
statistically significant difference (p=0,00385) in 
favor of IMRT was found for volumes of femoral 
heads receiving lower doses (30Gy, V30Gy). Zelef-
sky et al. have reported that no statistically signifi-
cant difference was found between planning tech-
niques when it comes to the incidence of long-
term hip-related toxicity (15).
CONCLUSION
The statistically significant difference in tar-
get volume coverage by 100% of the absorbed 
dose was found for PTV1 and ptV2; better cover-
age being achieved with IMRT.
No statistically significant difference in favor 
of IMRT was found for organs-at-risk sparing, ex-
cept in the case for a volume of the rectum which 
receives 40 Gy (V40Gy) and in the case for a volume 
of femoral heads which receives 30Gy (V30Gy).
Expectedly, better results were achieved for 
IMRT (16). However, differences between the FiF 
technique and the IMRT for prostate cancer treat-
ment were shown to be statistically insignificant 
for most analyzed parameters, which point to the 
fact that well-planned and executed radiation on-
cology treatment of prostate cancer by using the 
3-DCRT FiF technique can also be considered as a 
technique of choice.
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Sažetak
UTJECAJ IZBORA TEHNIKE PLANIRANJA FiF/IMRT KOD RADIOTERAPIJE OPERIRANE PROSTATE
N. Obajdin, Đ. Smilović Radojčić, D. Zahirović, M. Švabić Kolacio, D. Rajlić, I. Belac Lovasić i S. Jurković
Uvod: U posljedna dva desetljeća, u liječenju raka prostate radioterapijom postignut je veliki napredak. U KBC-u Rije-
ka, od 2016., jakosno modulirana radioterapija (IMRT) postaje tehnika izbora kod radioterapije operiranog raka prostate. Do 
tada je tehnika izbora bila napredna 3D konformalna radioterapija (3DCRT) korištenjem tehnike „polja u polju” (FiF). Istra-
živanje je provedeno s ciljem ispitivanja utjecaja izbora tehnike planiranja (FiF ili IMRT) na doznu pokrivenost ciljnih volu-
mena i poštedu organa rizika.
Metode i materijali: Usporedba raspodjela doze izračunate koristeći FiF i IMRT retrospektivno je učinjena kod deset 
bolesnika kojima je indicirana postoperativna radioterapija. Svim je bolesnicima predana propisana doza IMRT tehnikom, 
a za potrebe ovog istraživanja izračunate su i raspodjele doze FiF tehnikom. Da bi se utvrdilo utječe li tehnika planiranja na 
raspodjelu doze, analizirani su parametri važni za ciljne volumene (GTV, CTV, PTV1, ptV2), a kod analize poštede organa 
rizika (rektum, mokraćni mjehur i glavice femura) korištena su dozno-volumna ograničenja.
Rezultati i diskusija: Analizom parametara vezanih za ciljne volumene utvrđeno je da kod većine (V100%(GTV), 
V100%(CTV), V95%(PTV2), V95%(PTV1) nema statistički značajne razlike. Kod obje tehnike postignuta su dozna ograničenja 
propisana međunarodnim smjernicama.
Statistički značajna razlika utvrđena je kod V100%(PTV2), p=0,000534 i V100%(PTV1), p=0,042944 u prilog korištenja 
IMRT tehnike. Utvrđena je statistički značajna razlika (p=0,045966) za volumen rektuma koji prima 40Gy, kao i za volumen 
glavica femura koji prime apsorbiranu dozu 30Gy. U oba slučaja pošteda organa rizika bolja je korištenjem IMRT tehnike. 
Za promatrana dozno-volumna ograničenja vezana uz mokraćni mjehur nije utvrđena statistički značajna razlika.
Zaključak: Rezultati istraživanja pokazuju statistički značajnu razlikukod usporedbe volumena kojemu je predana pro-
pisana apsorbirana doza (V100%) za PTV1 i ptV2, tako da je bolja dozna pokrivenost kod IMRT tehnike. Pri poštedi organa 
rizika statistički značajna razlika u korist IMRT-a utvrđena je kod analize volumena rektuma kojem je predana apsorbirana 
doza od 40Gy i volumena glavica femura kojima je predana apsorbirana doza od 30Gy. Prema očekivanju, IMRT daje bolje 
rezultate. Međutim, razlike u analiziranim parametrima između dvije tehnike planiranja (FiF ili IMRT) kod većine analizi-
ranih parametara nisu statistički značajne što upućuje da kvalitetno planirana radioterapija FiF tehnikom može također biti 
tehnika izbora.
KLJUČNE RIJEČI:  jakosno modulirana radioterapija IMRT, tehnika „polja u polju”, radioterapija operiranog raka prostate,  
dozimetrija
